Search
forResearch 10 of 221
- Clinical development and management of adverse events associated with FGFR inhibitors
- Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist
- An epidermis‐permeable dipeptide is a potential cosmetic ingredient with partial agonist/antagonist activity toward fibroblast growth factor receptors
- ポ-トフォリオを使った社会科教育法の授業実践--ポ-トフォリオによるカリキュラム改革と教師の力量形成(2)
- Screening the Chemical Composition and Bioactivity of <i>Cerasus serrulata</i> Flower Extracts Using Two Extraction Methods
- FGF Family: From Drug Development to Clinical Application
- EX VIVO DRUG SENSITIVITY EVALUATION OF A RARE ZMYM2::FGFR1+ LEUKEMIA PATIENT
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Antisense oligonucleotide targeting fibroblast growth factor receptor (FGFR)-1 stimulates cellular activity of hair follicles in an<i>in vitro</i>organ culture system
- New Activators and Inhibitors in the Hair Cycle Clock: Targeting Stem Cells’ State of Competence
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →